Stay updated on Daratumumab for AML/High-Risk MDS Clinical Trial

Sign up to get notified when there's something new on the Daratumumab for AML/High-Risk MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab for AML/High-Risk MDS Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing v3.6.4. This indicates a small update to the page's version metadata, with no changes to the study information.
    Difference
    0.1%
    Check dated 2026-08-08T23:28:44.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Expanded the study record with additional sections and documents, including the study protocol and statistical analysis plan PDF, sponsor/collaborator details, and updated dates and outcome measures. These additions provide deeper context about the trial's design, interventions, and results timeline.
    Difference
    47%
    Check dated 2026-08-01T20:03:35.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.6.4 added. A broad set of institutional names, document references, and related metadata were removed from the study record, indicating metadata cleanup rather than changes to the study design or eligibility.
    Difference
    17%
    Check dated 2026-07-25T17:44:47.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision label changed from v3.6.2 to v3.6.3, indicating a minor version update to the page. This update is administrative and does not alter the page's substantive information.
    Difference
    0.1%
    Check dated 2026-07-04T13:18:47.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.0 to v3.6.2. This appears to be a minor metadata update with no substantive changes to the study information or page content.
    Difference
    0.1%
    Check dated 2026-06-27T06:37:20.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page now includes new user-help sections (No longer looking for participants; How to Read a Study Record; Common Questions; How to Join a Study) and a new revision tag (Revision: v3.6.0). The older label 'Intervention / Treatment' and the earlier revision tag (Revision: v3.5.5) were removed.
    Difference
    0.6%
    Check dated 2026-06-13T01:20:00.000Z thumbnail image

Stay in the know with updates to Daratumumab for AML/High-Risk MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab for AML/High-Risk MDS Clinical Trial page.